瘤缺氧影响了自然杀手细胞的抗癌活动
Mauricio A Retamal1, Flavio Salazar-Onfray2,3,4, Fermín E González5
1Programa de Comunicación en Cáncer, Facultad de Medicina, Instituto de Ciencias E Innovación en Medicina, Clínica Alemana Universidad del Desarrollo, 7610634, Santiago, Chile.
概括
瘤缺氧会损害自然杀手 (NK) 细胞的功能,阻碍癌症免疫力和免疫治疗. 本综述探讨了缺氧如何影响NK细胞,并讨论了克服这些挑战的策略,以获得更好的癌症治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 瘤缺氧是瘤微环境 (TME) 中的一个关键因素.
- 缺氧显著损害了自然杀手 (NK) 细胞的抗瘤功能.
- NK细胞对于癌症免疫监测和免疫疗法的有效性至关重要.
研究的目的:
- 综合审查瘤缺氧抑制NK细胞活动的机制.
- 要突出分子通路和细胞适应参与NK细胞逃避由癌细胞.
- 讨论克服缺氧诱导免疫抑制的新兴策略,以增强癌症免疫治疗.
主要方法:
- 对瘤缺氧和NK细胞功能研究的文献综述.
- 对将低氧与NK细胞细胞毒性受损联系起来的分子和细胞机制的分析.
- 针对低氧性TME的现有和新兴治疗策略的综合.
主要成果:
- 缺氧使缺氧诱导因素稳定,促进新陈代谢重编程,血管生成和癌症干.
- 缺氧诱导免疫抑制分子和癌症和NK细胞的表型/功能变化.
- 这些适应导致瘤的进展和对免疫治疗的抵抗.
结论:
- 向缺氧诱导的免疫抑制对于改善癌症免疫治疗至关重要.
- 像纳米技术,细胞因子预调和血管正常化等策略显示出有希望.
- 在低氧性TME中增强NK细胞功能可以与现有的癌症疗法协同作用,以获得更好的结果.
相关概念视频
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K


